Why the study?
Does ECMO improve survival in patients with acute respiratory failure related to granulomatosis with polyangiitis?
Does ECMO improve survival in patients with acute respiratory failure related to granulomatosis with polyangiitis?
ECMO may serve as an effective rescue therapy for patients with life-threatening acute respiratory failure due to granulomatosis with polyangiitis, allowing time for immunosuppressive treatment to take effect.
May temporize refractory GPA-related DAH to permit diagnosis and therapy; leaves open whether ECMO improves survival.
Granulomatosis with polyangiitis (GPA) is a subtype of anti-neutrophil cytoplasmic antibody-associated vasculitis with a wide range of clinical symptoms related to the systemic involvement of small blood vessels. The respiratory system is one of the most frequently involved, and life-threatening acute respiratory failure could occur due to diffusive alveolar hemorrhage and tracheal stenosis. When maximum mechanical ventilation is unable to maintain oxygenation, extracorporeal membrane oxygenation (ECMO) should be considered as the final respiratory supportive method, if available. Here we present a 32-year-old male patient with acute respiratory failure (ARF) related to GPA, who was rescued by winning time for accurate diagnosis and appropriate treatment. Additionally, we reviewed more than 60 GPA-related ARF cases on multiple online databases, summarized the clinical manifestations of these patients, and concluded that ECMO plays an important role in further respiratory support for ARF patients with GPA and assists in accurate and timely diagnosis and appropriate treatment, thus helping them recuperate.
No takes yet. Share an insight, caveat, or question.
Wan et al. (2021) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: